Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks Patients on semaglutide lost an average of 13.7% of their body weight over the same period 47% more tirzepatide patients achieved 25% or greater body weight loss compared to semaglutide Tirzepatide also produced greater reductions in waist circumference across all dose comparisons A 2024 meta-analysis published in JAMA Internal Medicine analyzing real-world data from over 140,000 patients confirmed the same pattern: tirzepatide produced an average of 4.23 kg more weight loss than semaglutide across all doses and durations studied
Gastroprotection should be considered in these higher-risk scenarios according to NICE Clinical Knowledge Summaries guidance
Supports Liver Health: Glutathione is crucial for liver detoxification
Peters R (2006) Ageing and the brain
CONTRAINDICATIONS BOOK NOW Active Melanoma or Skin Cancer: Avoid use as MT2 stimulates melanin production
One of the initial discussions that is had when people are diagnosed is around weight management, because for people who are obese, it's been shown that weight reduction can ease symptoms
